Theravance Biopharma (TBPH) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Theravance Biopharma (TBPH) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.59% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -76.72% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 85.51% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 12.13% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 90.10% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -48.36% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,170.12% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 99.48% |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | -2,449.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,449.14% |
| Mar 31, 2026 | -560.07% |
| Dec 31, 2025 | 3,459.63% |
| Sep 30, 2025 | 34.51% |
| Jun 30, 2025 | 83.15% |
| Mar 31, 2025 | -25.99% |
| Dec 31, 2024 | -35.13% |
| Sep 30, 2024 | -19.59% |
| Jun 30, 2024 | 14.09% |
| Mar 31, 2024 | 60.66% |
| Sep 30, 2023 | -143.04% |
| Jun 30, 2023 | -125.68% |
| Mar 31, 2023 | -151.40% |
| Sep 30, 2022 | 76.42% |
| Jun 30, 2022 | -127.82% |
| Mar 31, 2022 | -208.94% |
| Dec 31, 2021 | -64.57% |
| Sep 30, 2021 | -279.16% |
| Jun 30, 2021 | 12.87% |
| Mar 31, 2021 | 20.01% |